Cautionary Tale: Excess Toxicity With DNA-Dependent Protein Kinase Inhibitor and Concurrent Cisplatin-Based Chemoradiation for Head and Neck Cancer

Int J Radiat Oncol Biol Phys. 2024 Mar 1;118(3):757-758. doi: 10.1016/j.ijrobp.2023.10.003.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Antineoplastic Agents* / adverse effects
  • Chemoradiotherapy / adverse effects
  • Cisplatin
  • DNA-Activated Protein Kinase
  • Head and Neck Neoplasms* / drug therapy
  • Humans
  • Squamous Cell Carcinoma of Head and Neck / drug therapy

Substances

  • Cisplatin
  • DNA-Activated Protein Kinase
  • Antineoplastic Agents